MoneyWorks4Me

FDC - Quaterly Results

06 Aug 2026 Evaluate
The Total revenue for the quarter ended June 2026 of  Rs. 6551.00 millions remain, more or less, the same.The Company has registered profit of Rs. 1320.20  millions for the quarter ended June 2026, a growth of 8.04%  over Rs. 1222.00 millions millions achieved in the corresponding quarter of last year.Operating profit for the quarter ended June 2026 rose to 1901.80 millions as compared to 1769.20 millions of corresponding quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 6551.00 6422.80 2.00 6551.00 6422.80 2.00 21263.27 20701.12 2.72
Other Income 473.40 355.90 33.01 473.40 355.90 33.01 1110.01 1055.18 5.20
PBIDT 1901.80 1769.20 7.49 1901.80 1769.20 7.49 4631.81 4257.65 8.79
Interest 8.20 11.60 -29.31 8.20 11.60 -29.31 49.24 44.88 9.71
PBDT 1893.60 1757.60 7.74 1893.60 1757.60 7.74 4374.68 4212.77 3.84
Depreciation 150.90 148.70 1.48 150.90 148.70 1.48 591.04 536.06 10.26
PBT 1742.70 1608.90 8.32 1742.70 1608.90 8.32 3783.64 3676.71 2.91
TAX 422.50 386.90 9.20 422.50 386.90 9.20 924.40 940.46 -1.71
Deferred Tax 25.50 36.90 -30.89 25.50 36.90 -30.89 61.40 90.46 -32.12
PAT 1320.20 1222.00 8.04 1320.20 1222.00 8.04 2859.24 2736.25 4.49
Equity 162.80 162.80 0.00 162.80 162.80 0.00 162.81 162.81 0.00
PBIDTM(%) 29.03 27.55 5.39 29.03 27.55 5.39 21.78 20.57 5.91
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..